The 77th Annual Meeting of the American Academy of Neurology (AAN 2025), held from April 5–9 in San Diego and online, served as a pivotal forum for advancing research in neurology, with particular relevance to neurodegenerative diseases. As one of the largest gatherings of neurologists globally, the conference provided a critical platform for unveiling new data, fostering cross-disciplinary collaboration, and translating scientific discoveries into clinical strategies.
For the neurodegenerative disease field—spanning Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and others—AAN 2025 delivered high-impact presentations that addressed gaps in diagnosis...
